LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 1 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 1. - Dataset (ID:20309)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Trametinib | 0.001 | 71.54 | 771.67 | 8101 | 10532 | 0.7691 | 0.8655 | MN20160304_L01 | H11 |
| MCF 10A-H2B-mCherry | Trametinib | 0.001 | 71.54 | 771.67 | 10027 | 10532 | 0.9520 | 0.9741 | MN20160304_L01 | M13 |
| MCF 10A-H2B-mCherry | Trametinib | 0.001 | 73.76 | 771.67 | 8241 | 10851 | 0.7594 | 0.8608 | MN20160304_L01 | H11 |
| MCF 10A-H2B-mCherry | Trametinib | 0.001 | 73.76 | 771.67 | 10261 | 10851 | 0.9456 | 0.9709 | MN20160304_L01 | M13 |
| MCF 10A-H2B-mCherry | Trametinib | 0.001 | 76.02 | 771.67 | 8587 | 11106 | 0.7731 | 0.8706 | MN20160304_L01 | H11 |
| MCF 10A-H2B-mCherry | Trametinib | 0.001 | 76.02 | 771.67 | 10595 | 11106 | 0.9539 | 0.9756 | MN20160304_L01 | M13 |
| MCF 10A-H2B-mCherry | Trametinib | 0.001 | 78.25 | 771.67 | 8840 | 11367 | 0.7776 | 0.8745 | MN20160304_L01 | H11 |
| MCF 10A-H2B-mCherry | Trametinib | 0.001 | 78.25 | 771.67 | 11057 | 11367 | 0.9727 | 0.9858 | MN20160304_L01 | M13 |
| MCF 10A-H2B-mCherry | Trametinib | 0.001 | 80.48 | 771.67 | 9089 | 11685 | 0.7778 | 0.8759 | MN20160304_L01 | H11 |
| MCF 10A-H2B-mCherry | Trametinib | 0.001 | 80.48 | 771.67 | 11485 | 11685 | 0.9829 | 0.9912 | MN20160304_L01 | M13 |
| MCF 10A-H2B-mCherry | Trametinib | 0.001 | 82.69 | 771.67 | 9240 | 11974 | 0.7717 | 0.8732 | MN20160304_L01 | H11 |
| MCF 10A-H2B-mCherry | Trametinib | 0.001 | 82.69 | 771.67 | 11898 | 11974 | 0.9937 | 0.9968 | MN20160304_L01 | M13 |
| MCF 10A-H2B-mCherry | Trametinib | 0.001 | 84.92 | 771.67 | 9555 | 12266 | 0.7789 | 0.8786 | MN20160304_L01 | H11 |
| MCF 10A-H2B-mCherry | Trametinib | 0.001 | 84.92 | 771.67 | 12233 | 12266 | 0.9973 | 0.9986 | MN20160304_L01 | M13 |
| MCF 10A-H2B-mCherry | Trametinib | 0.001 | 87.14 | 771.67 | 9677 | 12592 | 0.7685 | 0.8734 | MN20160304_L01 | H11 |
| MCF 10A-H2B-mCherry | Trametinib | 0.001 | 87.14 | 771.67 | 12725 | 12592 | 1.0105 | 1.0052 | MN20160304_L01 | M13 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 2.49 | 771.67 | 869 | 867 | 1.0014 | 1.0171 | MN20160304_L01 | C03 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 2.49 | 771.67 | 935 | 867 | 1.0775 | 2.1082 | MN20160304_L01 | N08 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 4.71 | 771.67 | 956 | 956 | 0.9996 | 0.9975 | MN20160304_L01 | C03 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 4.71 | 771.67 | 1075 | 956 | 1.1240 | 1.9178 | MN20160304_L01 | N08 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 6.94 | 771.67 | 1045 | 1045 | 0.9999 | 0.9995 | MN20160304_L01 | C03 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 6.94 | 771.67 | 1175 | 1045 | 1.1243 | 1.6138 | MN20160304_L01 | N08 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 9.16 | 771.67 | 1113 | 1138 | 0.9776 | 0.9209 | MN20160304_L01 | C03 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 9.16 | 771.67 | 1259 | 1138 | 1.1058 | 1.3928 | MN20160304_L01 | N08 |
| MCF 10A-H2B-mCherry | Trametinib | 0.0016667 | 11.56 | 771.67 | 1265 | 1280 | 0.9878 | 0.9667 | MN20160304_L01 | C03 |